Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia
British Journal of Haematology · 2025-01 · 206 (1) · 133-143
DOI: 10.1111/bjh.19760 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 23.09.2024. Verfasst von Yizhi Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. Hauptthemen laut MEDLINE: Proteomics, Purpura, Thrombocytopenic, Idiopathic, Blood Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Key Research and Development Project of Anhui Province, Initiation Fund Project of The First Affiliated Hospital of Wannan Medical College, National Natural Science Foundation of China.
Abstract (Originalsprache)
The lack of biomarkers for accurate diagnosis and prognosis is a major clinical challenge of primary immune thrombocytopaenia (ITP). Using an Olink proteomics platform with a 92 immune response‐related human protein panel, we analysed plasma samples from ITP patients (ITP, n = 40), patients with thrombocytopaenia secondary to other causes (Non‐ITP, n = 19) and healthy controls (NC, n = 18), of a discovery cohort as well as a validation cohort (ITP, n = 36; NC, n = 20). A total of 10 differentially expressed proteins (DEPs) were identified in the ITP group compared with the non‐ITP and NC groups of the discovery cohort. These include CXCL11, GZMH, ARG1, TGF‐β1, ANGPT1, CXCL12, CD40‐L, PDGF subunit B, IL4 and TNFSF14. Furthermore, least absolute shrinkage and selection operator regression analysis showed some of these DEPs, such as CXCL11, TGF‐β1, ARG1 and GZMH to be significant in differentiating between patients with ITP and healthy controls (validation area under the curve = 0.87). The analysis demonstrated that the ITP group has a specific proteomic profile relative to non‐ITP and NC groups. In summary, we report for the first time that Olink precision proteomics can specifically detect up‐regulated inflammatory proteins as potential diagnostic biomarkers for ITP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
- NHC Key Laboratory of Thrombosis and Hemostasis, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
- Department of Nuclear Medicine, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
ORCID-Profile: Yizhi Jiang, Lu Zhou
Förderung
- Key Research and Development Project of Anhui Province
- Initiation Fund Project of The First Affiliated Hospital of Wannan Medical College
- National Natural Science Foundation of China
- NHC Key Laboratory of Thrombosis and Hemostasis
- Program in Universities of Anhui Province
- Wuhu Science and Technology Plan Project
- Anhui Provincial Key Research and Development Plan
Zitieren
APA
Jiang, Y., Li, J., Huang, J., Zhang, Z., Liu, X., Wang, N., Huang, C., Wang, R., Zhang, L., Han, J., Bai, X., Huang, D., & Zhou, L. (2025). Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia. British Journal of Haematology, 206(1), 133-143. https://doi.org/10.1111/bjh.19760
Vancouver
Jiang Y, Li J, Huang J, Zhang Z, Liu X, Wang N, et al. Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia. British Journal of Haematology. 2025;206(1):133-143. doi:10.1111/bjh.19760
BibTeX
@article{Jiang2025,
author = {Jiang, Yizhi and Li, Jizhe and Huang, Jun and Zhang, Zichan and Liu, Xiaocen and Wang, Nana and Huang, Chen and Wang, Ran and Zhang, Lanxin and Han, JingJing and Bai, Xia and Huang, Dongping and Zhou, Lu},
title = {Targeted proteomics profiling reveals valuable biomarkers in the diagnosis of primary immune thrombocytopaenia},
journal = {British Journal of Haematology},
year = {2025},
volume = {206},
number = {1},
pages = {133--143},
doi = {10.1111/bjh.19760}
}
EUVIMED